These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3966923)

  • 1. Antitumour imidazotetrazines--VIII. Uptake and decomposition of a novel antitumour agent mitozolomide (CCRG 81010; M and B 39565; NSC 353451) in TLX5 mouse lymphoma in vitro.
    Horgan CM; Tisdale MJ
    Biochem Pharmacol; 1985 Jan; 34(2):217-21. PubMed ID: 3966923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumour imidazotetrazines--IV. An investigation into the mechanism of antitumour activity of a novel and potent antitumour agent, mitozolomide (CCRG 81010, M & B 39565; NSC 353451).
    Horgan CM; Tisdale MJ
    Biochem Pharmacol; 1984 Jul; 33(14):2185-92. PubMed ID: 6147140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumour imidazotetrazines--XVI. Macromolecular alkylation by 3-substituted imidazotetrazinones.
    Bull VL; Tisdale MJ
    Biochem Pharmacol; 1987 Oct; 36(19):3215-20. PubMed ID: 2444229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine.
    Stevens MF; Hickman JA; Langdon SP; Chubb D; Vickers L; Stone R; Baig G; Goddard C; Gibson NW; Slack JA
    Cancer Res; 1987 Nov; 47(22):5846-52. PubMed ID: 3664486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental antitumor activity against murine tumor model systems of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one (mitozolomide), a novel broad-spectrum agent.
    Hickman JA; Stevens MF; Gibson NW; Langdon SP; Fizames C; Lavelle F; Atassi G; Lunt E; Tilson RM
    Cancer Res; 1985 Jul; 45(7):3008-13. PubMed ID: 4005840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cellular esterases by the antitumour imidazotetrazines mitozolomide and temozolomide: demonstration by flow cytometry and conventional spectrofluorimetry.
    Dive C; Workman P; Watson JV
    Cancer Chemother Pharmacol; 1989; 25(3):149-55. PubMed ID: 2557170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumour imidazotetrazines, Part IX. The pharmacokinetics of mitozolomide in mice.
    Goddard C; Slack JA; Stevens MF
    Br J Cancer; 1985 Jul; 52(1):37-41. PubMed ID: 4015951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumour imidazotetrazines. Part 37. Conjugation of the DNA major-groove alkylating imidazotetrazine mitozolomide to peptide motifs recognizing the minor groove.
    Arrowsmith J; Missailidis S; Stevens MF
    Anticancer Drug Des; 1999 Jun; 14(3):205-17. PubMed ID: 10500496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodistribution and metabolism of orally administered mitozolomide in mice.
    Gachon F; Labarre P; Godeneche D; Moreau MF; Papon J; Madelmont JC; Veyre A; Gaillard G
    Drug Metab Dispos; 1993; 21(4):560-6. PubMed ID: 8104113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor imidazotetrazines. 20. Preparation of the 8-acid derivative of mitozolomide and its utility in the preparation of active antitumor agents.
    Horspool KR; Stevens MF; Newton CG; Lunt E; Walsh RJ; Pedgrift BL; Baig GU; Lavelle F; Fizames C
    J Med Chem; 1990 May; 33(5):1393-9. PubMed ID: 2329560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumour imidazotetrazines-X. Effect of 8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4-(3H)-one (CCRG 81045; M & B 39831; NSC 362856) on DNA methylation during induction of haemoglobin synthesis in human leukaemia cell line K562.
    Tisdale MJ
    Biochem Pharmacol; 1986 Jan; 35(2):311-6. PubMed ID: 3455809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative studies between the effects of mitozolomide and two novel tetrazepinones PYRCL and QUINCL on NIH:OVCAR-3 cells.
    Jean-Claude BJ; Mustafa A; Damian Z; De Marte J; Vasilescu DE; Yen R; Chan TH; Leyland-Jones B
    Cancer Chemother Pharmacol; 1998; 42(1):59-67. PubMed ID: 9619759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and murine pharmacokinetics of the 8-(N,N-dimethylcarboxamide) analogue of the experimental antitumor drug mitozolomide (NSC353451).
    Horspool KR; Quarterman CP; Slack JA; Gescher A; Stevens MF; Lunt E
    Cancer Res; 1989 Sep; 49(18):5023-6. PubMed ID: 2766272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of mitozolomide (NSC 353451), a new imidazotetrazine, against xenografts from human melanomas, sarcomas, and lung and colon carcinomas.
    Fodstad O; Aamdal S; Pihl A; Boyd MR
    Cancer Res; 1985 Apr; 45(4):1778-86. PubMed ID: 3978640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The logistics of broader pre-clinical evaluation of potential anti-cancer agents with reference to anti-tumour activity and toxicity of mitozolomide.
    Bibby MC; Double JA; Wahed IA; Hirbawi N; Baker TG
    Br J Cancer; 1988 Aug; 58(2):139-43. PubMed ID: 3166903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma and tissue disposition of mitozolomide in mice.
    Brindley CJ; Antoniw P; Newlands ES
    Br J Cancer; 1986 Jan; 53(1):91-7. PubMed ID: 3456242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the antitumor agent 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one on the DNA of mouse L1210 cells.
    Gibson NW; Erickson LC; Hickman JA
    Cancer Res; 1984 May; 44(5):1767-71. PubMed ID: 6713380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 8-Acid derivative of the antitumour agent mitozolomide.
    Lowe PR; Schwalbe CH
    Acta Crystallogr C; 1995 May; 51 ( Pt 5)():937-9. PubMed ID: 7779325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor imidazotetrazines--XV. Role of guanine O6 alkylation in the mechanism of cytotoxicity of imidazotetrazinones.
    Tisdale MJ
    Biochem Pharmacol; 1987 Feb; 36(4):457-62. PubMed ID: 3470008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor imidazotetrazines. 1. Synthesis and chemistry of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one , a novel broad-spectrum antitumor agent.
    Stevens MF; Hickman JA; Stone R; Gibson NW; Baig GU; Lunt E; Newton CG
    J Med Chem; 1984 Feb; 27(2):196-201. PubMed ID: 6694168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.